Table 1 Screening of serum chemokines and cytokines as complementary biomarkers for early diagnosis and prognosis of congenital toxoplasmosis.
From: Putative biomarkers for early diagnosis and prognosis of congenital ocular toxoplasmosis
Diagnosis | Early prognosis | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Biomarkersa (pg/mL) | CTL × TOXO | Biomarkersb (pg/mL) | TOXO (NL × L) | Biomarkersc (pg/mL) | TOXO (AL × CL) | ||||||
AUC | Se (%) | Sp (%) | AUC | Se (%) | Sp (%) | AUC | Se (%) | Sp (%) | |||
CXCL9 | 0.9 | 84 | 81 | IL-5 | 0.6 | 92 | 28 | IL-12p70 | 0.6 | 91 | 30 |
CXCL10 | 0.8 | 82 | 69 | TNF | 0.6 | 78 | 50 | IL-6 | 0.6 | 87 | 30 |
CCL5 | 0.6 | 83 | 42 | CXCL8 | 0.6 | 68 | 50 | CCL2 | 0.6 | 84 | 37 |
CXCL8 | 0.6 | 68 | 50 | IL-6 | 0.6 | 62 | 61 | CCL5 | 0.6 | 78 | 37 |
IFN-γ | 0.6 | 58 | 65 | CCL2 | 0.6 | 61 | 72 | IL-17A | 0.6 | 72 | 46 |
IL-12p70 | 0.6 | 56 | 61 | IFN-γ | 0.6 | 55 | 72 | IL-4 | 0.6 | 63 | 52 |
IL-1β | 0.6 | 52 | 65 | CCL5 | 0.6 | 40 | 78 | IL-1β | 0.5 | 96 | 15 |
TNF | 0.6 | 31 | 83 | IL-17A | 0.5 | 83 | 33 | IL-10 | 0.5 | 94 | 21 |
IL-10 | 0.5 | 91 | 22 | IL-1β | 0.5 | 81 | 39 | CXCL8 | 0.5 | 93 | 17 |
CCL2 | 0.5 | 91 | 23 | IL-4 | 0.5 | 71 | 50 | IL-5 | 0.5 | 93 | 27 |
IL-17A | 0.5 | 91 | 22 | CXCL9 | 0.5 | 68 | 50 | IFN-γ | 0.5 | 59 | 52 |
IL-4 | 0.5 | 85 | 30 | IL-12p70 | 0.5 | 51 | 61 | TNF | 0.5 | 48 | 70 |
IL-5 | 0.5 | 51 | 70 | IL-10 | 0.5 | 46 | 72 | CXCL9 | 0.5 | 40 | 74 |
IL-6 | 0.5 | 42 | 74 | CXCL10 | 0.5 | 13 | 100 | CXCL10 | 0.5 | 31 | 86 |